{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:44:25Z","timestamp":1772793865475,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Bureau of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Diagnosing primary central nervous system lymphoma (PCNSL) remains a challenge. MicroRNAs (miRNAs) are promising noninvasive markers for the identification of PCNSL. The present study aims to assess the diagnostic value of miRNAs for PCNSL patients as biomarkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically searched PubMed, Embase, and the Cochrane library from inception to January 31, 2021. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), together with the summary receiver operator characteristic (SROC) curve, and the area under the SROC curve (AUC) value were used to estimate the overall diagnostic performance. We used Q statistic and I<jats:sup>2<\/jats:sup> to test heterogeneity and used subgroup analyses to investigate the source of heterogeneity. The statistical analyses were independently performed by two investigators using Stata 14.0 and Revman 5.3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 11 studies from 6 records were included in the current meta-analysis with 281 PCNSL patients and 367 controls. Our statistical analysis demonstrated that the pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.91 (95% CI 0.84\u20130.95), 0.88 (95% CI 0.84\u20130.91), 7.48 (95% CI 5.71\u20139.78), 0.11 (95% CI 0.06\u20130.19), 70 (95% CI 35\u2013142), and 0.90 (95% CI 0.87\u20130.92), respectively. The studies had substantial heterogeneity (I<jats:sup>2<\/jats:sup> = 54%, 95% CI 0\u2013100). Two subgroup analyses were conducted based on the type of specimen and miRNAs profiled.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This meta-analysis indicated that miRNAs were suitable as noninvasive diagnostic biomarkers for PCNSL with high accuracy. In addition, both cerebrospinal fluid-based and blood-based miRNAs assays for PCNSL detection were considered reliable for clinical application. MicroRNA-21 assays also seemed to be more accurate in the diagnosis of PCNSL. Good quality studies with large samples should be conducted to verify our results.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.743542","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T05:57:13Z","timestamp":1631858233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiaohong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parker","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoubo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2598","article-title":"Primary Central Nervous System Lymphoma: A Curable Disease","author":"Batchelor","year":"2019","journal-title":"Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12885-016-2311-4","article-title":"High-Dose Chemotherapy and Autologous Stem Cell Transplant Compared With Conventional Chemotherapy for Consolidation in Newly Diagnosed Primary CNS Lymphoma\u2013a Randomized Phase III Trial (MATRix)","volume":"16","author":"Schorb","year":"2016","journal-title":"BMC Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012","author":"Ostrom","year":"2015","journal-title":"Neuro-oncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.13.524","article-title":"Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma","volume":"23","author":"Abrey","year":"2005","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and Treatment of Primary CNS Lymphoma","volume":"9","author":"Korfel","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08928.x","article-title":"Current Strategies in the Diagnosis of Diffuse Large B-Cell Lymphoma of the Central Nervous System","volume":"156","author":"Baraniskin","year":"2012","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.3.390","article-title":"CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes","volume":"58","author":"Gleissner","year":"2002","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.critrevonc.2018.05.010","article-title":"Molecular Analysis in Liquid Biopsies for Diagnostics of Primary Central Nervous System Lymphoma: Review of Literature and Future Opportunities","volume":"127","author":"Hiemcke-Jiwa","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-308684","article-title":"Identification of microRNAs in the Cerebrospinal Fluid as Marker for Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System","volume":"117","author":"Baraniskin","year":"2011","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-013-1491-9","article-title":"Serum miR-21 is a Diagnostic and Prognostic Marker of Primary Central Nervous System Lymphoma","volume":"35","author":"Mao","year":"2014","journal-title":"Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06611.x","article-title":"MicroRNAs and Haematology: Small Molecules, Big Function","volume":"137","author":"Lawrie","year":"2007","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2634","article-title":"Causes and Consequences of microRNA Dysregulation in Cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in Body Fluid: A New Potential Biomarker for Cancer Diagnosis and Prognosis","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.24.9342","article-title":"Serum microRNA Signatures Identified in a Genome-Wide Serum microRNA Expression Profiling Predict Survival of non-Small-Cell Lung Cancer","volume":"28","author":"Hu","year":"2010","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.9941","article-title":"Role of miRNA-21 in the Diagnosis and Prediction of Treatment Efficacy of Primary Central Nervous System Lymphoma","volume":"17","author":"Yang","year":"2019","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111647","article-title":"Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas","volume":"11","author":"Zajdel","year":"2019","journal-title":"Cancers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60879-5","article-title":"Clinical Diagnosis of Depression in Primary Care: A Meta-Analysis","volume":"374","author":"Mitchell","year":"2009","journal-title":"Lancet (London England)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Internal Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The Performance of Tests of Publication Bias and Other Sample Size Effects in Systematic Reviews of Diagnostic Test Accuracy was Assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000146","article-title":"Serum microRNAs in HIV-Infected Individuals as Pre-Diagnosis Biomarkers for AIDS-NHL","volume":"66","author":"Thapa","year":"2014","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2749-0","article-title":"MicroRNA-30c as a Novel Diagnostic Biomarker for Primary and Secondary B-Cell Lymphoma of the CNS","volume":"137","author":"Baraniskin","year":"2018","journal-title":"J Neuro Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1447","article-title":"CT and MR Imaging Features of Primary Central Nervous System Lymphoma in Norway, 1989-2003","volume":"30","author":"Haldorsen","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-014-2145-2","article-title":"Frameless Image-Guided Stereotactic Brain Biopsies: Emphasis on Diagnostic Yield","volume":"156","author":"Khatab","year":"2014","journal-title":"Acta Neurochirurg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A Systematic Approach to the Diagnosis of Suspected Central Nervous System Lymphoma","volume":"70","author":"Scott","year":"2013","journal-title":"JAMA Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8822-6","article-title":"MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: A Meta-Analysis","volume":"51","author":"Wei","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bjh.15410","article-title":"Diagnostic Markers for CNS Lymphoma in Blood and Cerebrospinal Fluid: A Systematic Review","volume":"182","author":"van Westrhenen","year":"2018","journal-title":"Br J Haematol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov144","article-title":"Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Biomarker for Primary Central Nervous System Lymphoma","volume":"18","author":"Baraniskin","year":"2016","journal-title":"Neuro-Oncology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.9.7.11402","article-title":"MicroRNAs and Cancer Therapy: The Next Wave or Here to Stay","volume":"9","author":"Reddy","year":"2010","journal-title":"Cancer Biol Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.743542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T05:57:16Z","timestamp":1631858236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.743542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":29,"alternative-id":["10.3389\/fonc.2021.743542"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.743542","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"article-number":"743542"}}